Abstract
Design, results of in vitro antimycobacterial evaluation, and study of structure-activity relationships of various pyrazinecarboxylic acid reversible derivatives are presented. This review deals with some pyrazinamide analogues/prodrugs derived from Nphenylpyrazine- 2-carboxamides (1), arylaminopyrazine-2,5-dicarbonitriles (2), aryl/alkylsulphanylpyrazines (3,4), and aroylpyrazines (5) effecting > 50% inhibition in the primary antimycobacterial screen. The promising pyrazine candidates for further antimycobacterial evaluation were discovered. Results give good view onto structure-activity relationships of these analogues and promise even better activity of new compounds prepared after some structure optimization experiments.
Keywords: Pyrazines, in vitro antimycobacterial evaluation, structure-activity relationships, Tuberculosis, pyridine, esters, amide prodrugs, MIC (Minimal Inhibitory Concentration), Lawesson's reagent, Homolytic aroylation
Current Pharmaceutical Design
Title: Antimycobacterial Evaluation of Pyrazinoic Acid Reversible Derivatives
Volume: 17 Issue: 32
Author(s): Martin Dolezal, Diana Kesetovic and Jan Zitko
Affiliation:
Keywords: Pyrazines, in vitro antimycobacterial evaluation, structure-activity relationships, Tuberculosis, pyridine, esters, amide prodrugs, MIC (Minimal Inhibitory Concentration), Lawesson's reagent, Homolytic aroylation
Abstract: Design, results of in vitro antimycobacterial evaluation, and study of structure-activity relationships of various pyrazinecarboxylic acid reversible derivatives are presented. This review deals with some pyrazinamide analogues/prodrugs derived from Nphenylpyrazine- 2-carboxamides (1), arylaminopyrazine-2,5-dicarbonitriles (2), aryl/alkylsulphanylpyrazines (3,4), and aroylpyrazines (5) effecting > 50% inhibition in the primary antimycobacterial screen. The promising pyrazine candidates for further antimycobacterial evaluation were discovered. Results give good view onto structure-activity relationships of these analogues and promise even better activity of new compounds prepared after some structure optimization experiments.
Export Options
About this article
Cite this article as:
Dolezal Martin, Kesetovic Diana and Zitko Jan, Antimycobacterial Evaluation of Pyrazinoic Acid Reversible Derivatives, Current Pharmaceutical Design 2011; 17 (32) . https://dx.doi.org/10.2174/138161211798194477
DOI https://dx.doi.org/10.2174/138161211798194477 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Ceric Ammonium Nitrate Catalysed Stereoselective Synthesis of β-Aminoketones Using 3-Aryl-4-Formylsydnones
Letters in Organic Chemistry Nano-carriers for the Treatment of Tuberculosis
Recent Patents on Anti-Infective Drug Discovery The Potent Antiplasmodial Calmodulin-Antagonist Trifluoperazine Inhibits Plasmodium falciparum Calcium-Dependent Protein Kinase 4
Protein & Peptide Letters Occupational Respiratory Pathology in Russia: Current Trends and Challenges
Current Respiratory Medicine Reviews The Immunopathology of Tuberculosis – An Update
Current Respiratory Medicine Reviews Radiolabelled Peptides: Eon in Radiopharmaceutical
Current Radiopharmaceuticals Design, Synthesis, <i>In Silico</i> and <i>In Vitro</i> Studies of Substituted 1, 2, 3, 4- Tetrahydro Pyrimidine Phosphorus Derivatives
Combinatorial Chemistry & High Throughput Screening Mycobacterial Shikimate Pathway Enzymes as Targets for Drug Design
Current Drug Targets ent-Abietane Lactones from Euphorbia
Mini-Reviews in Medicinal Chemistry Peptide Nucleic Acids (PNAs) as Diagnostic Devices for Genetic and Cytogenetic Analysis
Current Pharmaceutical Design Hyperglycaemia and Vitamin D: A Systematic Overview
Current Diabetes Reviews Recent Developments in the Chemistry and Biology of G-Quadruplexes with Reference to the DNA Groove Binders
Current Pharmaceutical Design Computational Insight into the Binding Mechanism of Pyrazinoic Acid to RpsA Protein
Current Chinese Science Virulence on the Fly: Drosophila melanogaster as a Model Genetic Organism to Decipher Host-Pathogen Interactions
Current Drug Targets Application of Metabolomics in Drug Discovery, Development and Theranostics
Current Metabolomics An Efficient and Environmentally Benign Four-component Domino Protocol for Synthesis of Spirooxindoles Spiroannulated with Fused Heterosystems of Privileged Heterocycles
Current Bioactive Compounds Evaluation of Stationary Phases Made by Hydrosilation of Alkynes on Silica Hydride
Current Chromatography Vincristine-Induced Seizure Potentiated by Itraconazole Following RCHOP Chemotherapy for Diffuse Large B-Cell Lymphoma
Current Drug Safety Performance of Genotype MTBDRplus in the Detection of Resistance to Rifampicin and Isoniazid Among Clinical Mycobacteria Isolates in Ilorin, Nigeria
Current HIV Research Molecules and Metabolites from Natural Products as Inhibitors of Biofilm in Candida spp. pathogens
Current Topics in Medicinal Chemistry